Rossari Biotech Ltd (BOM:543213) reports an 18% revenue increase, driven by export growth and capacity expansion, despite challenges in pricing and profitability.

Grupa Kety SA (STU:GQ2) reports robust financial performance with significant revenue increases and strategic focus on future growth, despite facing challenging market conditions.

InspireMD Inc (NSPR) reports a 39% revenue increase driven by the US launch of CGuard Prime, despite a widened net loss and increased operating expenses.